Compounds > 1-hexadecyl-2-acetyl-glycero-3-phosphocholine
Page last updated: 2024-09-02

1-hexadecyl-2-acetyl-glycero-3-phosphocholine and carboplatin

1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with carboplatin in 1 studies

Compound Research Comparison

Studies
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Trials
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Recent Studies (post-2010)
(1-hexadecyl-2-acetyl-glycero-3-phosphocholine)		Studies
(carboplatin)		Trials
(carboplatin)		Recent Studies (post-2010) (carboplatin)
9,15618755212,8954,0015,244

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Alarcón, P; Burgos, RA; Mendez, N; Millán, C; Morera, FJ; Ojeda, J1

Other Studies

1 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and carboplatin

ArticleYear
Vincristine, carboplatin and cisplatin increase oxidative burst induced by PAF in canine neutrophils.
    Veterinary immunology and immunopathology, 2020, Volume: 221

    Topics: Animals; Antineoplastic Agents; Carboplatin; Cisplatin; Dogs; Matrix Metalloproteinase 9; Neutrophils; Platelet Activating Factor; Reactive Oxygen Species; Respiratory Burst; Vincristine

2020